140 related articles for article (PubMed ID: 6433676)
1. The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
Carlson RP; Datko LJ; Chang J; Nielsen ST; Lewis AJ
Agents Actions; 1984 Jun; 14(5-6):654-61. PubMed ID: 6433676
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid.
Carlson RP; Datko LJ; O'Neill-Davis L; Lewis AJ
J Immunopharmacol; 1986; 8(2):205-21. PubMed ID: 3487593
[TBL] [Abstract][Full Text] [Related]
3. The antiinflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid).
Gilman SC; Carlson RP; Chang J; Lewis AJ
Agents Actions; 1985 Oct; 17(1):53-9. PubMed ID: 3936345
[TBL] [Abstract][Full Text] [Related]
4. Mucosal lesions induced in the rat intestinal tract by the anti-inflammatory drug, Wy-41,770, a weak inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin inhibitor, indomethacin.
Rainsford KD
Toxicol Pathol; 1988; 16(3):366-75. PubMed ID: 3143146
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the antiinflammatory activity of fentiazac and its major metabolite, p-hydroxy fentiazac.
Chang J; Carlson RP; Lewis AJ
Agents Actions; 1984 Oct; 15(3-4):443-7. PubMed ID: 6441470
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis.
Cashin CH; Dawson W; Kitchen EA
J Pharm Pharmacol; 1977 Jun; 29(6):330-6. PubMed ID: 18568
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological properties of fenbufen. A review.
Sloboda AE; Tolman EL; Osterberg AC; Panagides J
Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
[TBL] [Abstract][Full Text] [Related]
8. Dibenztroponeacetic and -propionic acids. Potent new antiinflammatory agents.
Dunn JP; Green DM; Nelson PH; Rooks WH; Tomolonis A; Untch KG
J Med Chem; 1977 Dec; 20(12):1557-62. PubMed ID: 592320
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
Hidaka T; Hosoe K; Ariki Y; Takeo K; Yamashita T; Katsumi I; Kondo H; Yamashita K; Watanabe K
Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
[TBL] [Abstract][Full Text] [Related]
10. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
13. A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.
Gigler G; Kiszelly E; Tömpe P; Kovács G; Gadó K
Agents Actions Suppl; 1991; 32():39-43. PubMed ID: 1906236
[TBL] [Abstract][Full Text] [Related]
14. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase.
Laufer S; Tries S; Augustin J; Dannhardt G
Arzneimittelforschung; 1994 May; 44(5):629-36. PubMed ID: 8024637
[TBL] [Abstract][Full Text] [Related]
16. 4H-thieno[3,4-c]pyrazole derivatives with antiinflammatory, analgesic, antipyretic and platelet antiaggregating activities.
Menozzi G; Mosti L; Schenone P; D'Amico M; Filippelli A; Rossi F
Farmaco; 1992 Dec; 47(12):1495-511. PubMed ID: 1294166
[TBL] [Abstract][Full Text] [Related]
17. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.
Gaut ZN; Baruth H; Randall LO; Ashley C; Paulsrud JR
Prostaglandins; 1975 Jul; 10(1):59-66. PubMed ID: 807954
[TBL] [Abstract][Full Text] [Related]
18. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
Schillings RT; Sisenwine SF
Drug Metab Dispos; 1986; 14(4):405-12. PubMed ID: 2873986
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
[TBL] [Abstract][Full Text] [Related]
20. 2-[3-(1,1-Dimethylethyl)-5-methoxyphenyloxazolo[4,5-b]pyridine, a new topical antiinflammatory and analgesic compound lacking systemic activity and gastric side effects.
Bonney RJ; Olson BJ; Bach T; Beveridge G; Goldenberg MM; Gitterman CO; Humes JL; Lu AY; Hucker H; Dougherty H
Arzneimittelforschung; 1985; 35(4):715-20. PubMed ID: 3874629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
